DANAHER CORP /DE/ reported revenue of $6.26B for the period ended 2026-06-26, +5.5% year on year. Net income was $0.87B, a 13.9% net margin on a 57.6% gross margin. The largest revenue line is Revenuefrom Contractwith Customer Measurement Recurring at 35% of the total. Free cash flow for the period was $1.26B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | $6.26B | +5.5% |
| Gross profit | $3.61B | — |
| Operating income | $1.13B | — |
| Net income | $0.87B | +56.8% |
| Gross margin | 57.6% | Net margin 13.9% |
| Revenue Q/Q | +5.3% | — |
| Segment | Revenue | Share |
|---|---|---|
| Revenuefrom Contractwith Customer Measurement Recurring | $2.21B | 35.3% |
| Life Sciences | $1.88B | 30.0% |
| Revenuefrom Contractwith Customer Measurement Recurring | $1.72B | 27.5% |
| Revenuefrom Contractwith Customer Measurement Nonrecurring | $0.26B | 4.1% |
| Revenuefrom Contractwith Customer Measurement Nonrecurring | $0.20B | 3.2% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | $2.65B | 42.4% |
| R&D | $0.41B | 6.6% |
| SG&A | $2.07B | 33.1% |
| Tax & other | $0.26B | 4.1% |
| Item | Amount |
|---|---|
| Total assets | $92.37B |
| Total liabilities | $39.77B |
| Shareholders' equity | $52.59B |
| Equity / assets | 56.9% |
| Operating cash flow | $1.53B |
| Capital expenditure | $0.27B |
| Free cash flow | $1.26B |
| Cash conversion (OCF / net income) | 176% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
DRI ・ DDOG ・ DVA ・ DECK ・ DE ・ DELL ・ DAL ・ DVN ・ DXCM ・ FANG ・ DLR ・ DG
Source: SEC EDGAR · This page shows public filing data only, not investment advice. · Browse all companies